loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Edoxaban Tosylate Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Edoxaban Tosylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,912Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Hanseo Chem
    South Korea
    		 Hanseochem Co., Ltd. 2295-16-ND Edoxabantosilate hydrate 2021-07-07 Hanseochem Co., Ltd. South Korea 41 Poseung Industrial Complex-ro, Poseung-eup, Pyeongtaek-si, Gyeonggi-do
    28/09/2024 Korea Biochem Pharm
    South Korea
    		 Korea Biochem Pharmaceutical Co., Ltd. 2152-17-ND Edoxabantosilate hydrate 2022-05-31 Korea Biochem Pharmaceutical Co., Ltd. South Korea 204 Sandan-gil, Jeonui-myeon, Sejong Special Self-Governing City